In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Collegium Pharmaceutical Inc (NASDAQ: COLL) closed the day trading at $26.73 up 1.63% from the previous closing price of $26.30. In other words, the price has increased by $1.63 from its previous closing price. On the day, 0.62 million shares were traded. COLL stock price reached its highest trading level at $27.19 during the session, while it also had its lowest trading level at $26.25.
Ratios:
For a better understanding of COLL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.22. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.95. In the meantime, Its Debt-to-Equity ratio is 4.28 whereas as Long-Term Debt/Eq ratio is at 3.99.
On July 30, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $47.
Jefferies Upgraded its Hold to Buy on June 07, 2024, whereas the target price for the stock was revised from $41 to $44.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 ’25 when Tupper Colleen sold 6,396 shares for $30.03 per share. The transaction valued at 192,069 led to the insider holds 156,667 shares of the business.
Tupper Colleen sold 1,206 shares of COLL for $36,181 on Mar 20 ’25. The EVP & Chief Financial Officer now owns 163,063 shares after completing the transaction at $30.00 per share. On Mar 21 ’25, another insider, Dreyer Scott, who serves as the EVP & Chief Commercial Officer of the company, sold 18,881 shares for $30.03 each. As a result, the insider received 566,983 and left with 103,613 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COLL now has a Market Capitalization of 858883008 and an Enterprise Value of 1658755968. As of this moment, Collegium’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.47, and their Forward P/E ratio for the next fiscal year is 3.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.97. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.36 while its Price-to-Book (P/B) ratio in mrq is 3.67. Its current Enterprise Value per Revenue stands at 2.627 whereas that against EBITDA is 4.498.
Stock Price History:
The Beta on a monthly basis for COLL is 0.66, which has changed by -0.24491525 over the last 52 weeks, in comparison to a change of 0.07019031 over the same period for the S&P500. Over the past 52 weeks, COLL has reached a high of $42.29, while it has fallen to a 52-week low of $23.23. The 50-Day Moving Average of the stock is -8.72%, while the 200-Day Moving Average is calculated to be -18.65%.
Shares Statistics:
Over the past 3-months, COLL traded about 405.05K shares per day on average, while over the past 10 days, COLL traded about 483440 shares per day. A total of 31.44M shares are outstanding, with a floating share count of 30.91M. Insiders hold about 3.81% of the company’s shares, while institutions hold 117.40% stake in the company. Shares short for COLL as of 1743379200 were 4529665 with a Short Ratio of 11.18, compared to 1740700800 on 5412981. Therefore, it implies a Short% of Shares Outstanding of 4529665 and a Short% of Float of 16.830000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
